Madden Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Madden Securities's BMY Position: Q1 2026 in Review
Madden Securities held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 23,005 shares worth $1.4M. The position accounts for 0.42% of the portfolio, ranked #58.
Madden Securities first reported a position in BMY in Q4 2019 and has held it in 22 quarters since. The position peaked at $2.23M in Q2 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Madden Securities held 23,005 shares of Bristol-Myers Squibb worth $1.4M as of Q1 2026.
- Madden Securities left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.42% of Madden Securities's portfolio in Q1 2026, its #58 holding.
- Madden Securities first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 22 quarters since.
- Madden Securities's Bristol-Myers Squibb position peaked at $2.23M in Q2 2025.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Madden Securities's 13F filing for Q1 2026, filed 5 May 2026.